Richard Christopher
2016 - ICAD
In 2016, Richard Christopher earned a total compensation of $200.6K as Chief Financial Officer at ICAD.
Compensation breakdown
| Non-Equity Incentive Plan | $7,892 |
|---|---|
| Salary | $16,442 |
| Stock Awards | $175,000 |
| Other | $1,246 |
| Total | $200,580 |
Christopher received $175K in stock awards, accounting for 87% of the total pay in 2016.
Christopher also received $7.9K in non-equity incentive plan, $16.4K in salary and $1.2K in other compensation.
Rankings
In 2016, Richard Christopher's compensation ranked 13,393rd out of 14,075 executives tracked by ExecPay. In other words, Christopher earned more than 4.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,393 out of 14,075 | 5th |
Division Manufacturing | 5,235 out of 5,489 | 5th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 772 out of 827 | 7th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 469 out of 510 | 8th |
Industry Surgical and Medical Instruments and Apparatus | 286 out of 313 | 9th |
Source: SEC filing on October 20, 2017.
Christopher's colleagues
We found four more compensation records of executives who worked with Richard Christopher at ICAD in 2016.
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020